70 Views | 25 Downloads
Mark A. Underwood MD, MAS, Professor of Pediatrics, Chief, Division of Neonatology, UC Davis School of Medicine, 2516 Stockton Blvd, Sacramento, CA 95817, USA. Email: munderwood@ucdavis.edu
MAU: Wrote the initial and final drafts, EU edited initial draft and approved final draft, RMP edited initial draft and approved final draft.
MAU has received grant support from Evolve Bioscience, honoraria and travel support from Abbott, and received consulting fees from Avexegen. RMP has received honoraria and travel support from Mednax, Inc, partial travel support from Danone to attend the SIGNEC UK meeting, and consults for Shipman & Goodwin, LLP. MAU and RMP serve on the data-monitoring committee for a probiotic study conducted by Premier Research/Infant Bacterial Therapeutics. EU serves as a director of the NEC Society, the sponsor of the NEC Symposium and of this supplement to Pediatric Research. None of these entities had any role in this manuscript. The authors are not endorsing the use of any specific probiotic product.
MAU received funding from the NIH: R01 HD059127 and R21 HD096247;RMP received funding from the NIH: KL2 TR000455, UL1 TR000454, and K23 HL128942. The NIH had no role in: (1) study design; (2) the collection, analysis, and interpretation of data; (3) the writing of the report; and (4) the decision to submit the paper for publication.
Publication of this article was sponsored by the Necrotizing Enterocolitis (NEC) Society, Patient-Centered Outcomes Research Institute, and National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development.